STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype.

MLA

Della Corte, Carminia M., et al. “STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype.” Journal of Thoracic Oncology, vol. 15, no. 5, May 2020, pp. 777–91. EBSCOhost, https://doi.org/10.1016/j.jtho.2020.01.009.

APA

Della Corte, C. M., Sen, T., Gay, C. M., Ramkumar, K., Diao, L., Cardnell, R. J., Rodriguez, B. L., Stewart, C. A., Papadimitrakopoulou, V. A., Gibson, L., Fradette, J. J., Wang, Q., Fan, Y., Peng, D. H., Negrao, M. V., Wistuba, I. I., Fujimoto, J., Solis Soto, L. M., Behrens, C., & Skoulidis, F. (2020). STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype. Journal of Thoracic Oncology, 15(5), 777–791. https://doi.org/10.1016/j.jtho.2020.01.009

Chicago

Della Corte, Carminia M., Triparna Sen, Carl M. Gay, Kavya Ramkumar, Lixia Diao, Robert J. Cardnell, Bertha Leticia Rodriguez, et al. 2020. “STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype.” Journal of Thoracic Oncology 15 (5): 777–91. doi:10.1016/j.jtho.2020.01.009.